Arcellx, Inc.
ACLXDelisted Apr 28, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786205
Arcellx, Inc. was delisted on Apr 28, 2026; its insiders filed their last Form 4 on Apr 28, 2026; 240 institutions reported holding it in 13F filings for Q1 2026, worth $6.52B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding Arcellx, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 203 | 3 | 209 | +9 |
| Shares | 61.4M | 22.0K | 63.1M | +1.70M (+2.8%) |
| Value | $4.01B | $1.45M | $5.18B | +$1.17B (+29.1%) |
3 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (30)
Institutions that held Arcellx, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (21)
Institutions that held Arcellx, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Marshall Wace, LLP | 111,808 | $7.36M |
| Great Point Partners LLC | 100,000 | $6.58M |
| Decheng Capital LLC | 547,609 | $4.46M |
| Voloridge Investment Management, LLC | 66,422 | $4.37M |
| Trexquant Investment LP | 43,183 | $2.84M |
| Tudor Investment Corp Et Al | 23,197 | $1.53M |
| XTX Topco Ltd | 16,787 | $1.11M |
| Squarepoint Ops LLC | 16,044 | $1.06M |
| Qube Research & Technologies Ltd | 11,772 | $775.2K |
| Quantessence Capital LLC | 4,750 | $312.8K |
| EntryPoint Capital, LLC | 3,634 | $239.3K |
| Bellevue Group AG | 3,000 | $197.6K |
| Allostery Investments LP | 1,000 | $65.8K |
| Lazard Asset Management LLC | 735 | $48.0K |
| Turim 21 Investimentos Ltda. | 179 | $11.8K |
| Natixis | 80 | $5.27K |
| MPM Oncology Impact Management LP | 37 | $2.44K |
| Clearstead Advisors, LLC | 33 | $2.17K |
| Wolff Wiese Magana LLC | 17 | $1.12K |
| Skopos Labs, Inc. | 15 | $988 |
| Twin Peaks Wealth Advisors, LLC | 1 | $73 |
Not filed for Q3 2025 yet (3)
Institutions that held Arcellx, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 11,221 | $738.9K |
| E Fund Management Co., Ltd. | 6,293 | $414.4K |
| CIBC World Markets Corp | 4,511 | $297.0K |